Fund Overview of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular - Growth
-
₹165.5 CrAUM
-
₹20.82NAV
-
1.06%Expense Ratio
-
EquityFund Category
Returns of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular - Growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 3.19% | NA | 6.12% |
| 6 Months | 11.68% | NA | 12.92% |
| 1 Year | 0.50% | 0.50% | 6.04% |
| 2 Years | 43.76% | 19.90% | 24.93% |
| 3 Years | 69.07% | 19.13% | 25.71% |
Asset Allocation
equities
99.89%debt instruments
0.49%Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular - Growth is one Equity mutual fund offered by Edelweiss Mutual Fund. Launched on 26 Oct 2020, the fund aims Long Term Capital appreciation. Passive investment in equity and equity related securities replicating the composition of MSCI India Domestic & World Healthcare 45 Index, subject to tracking error. It manages assets worth ₹165.5 crore as on Thu Jul 31, 2025. The expense ratio stands at 1.06%. Fund Manager Manager Education Fund Manager Manager EducationAbout Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular - Growth
The portfolio allocation consists of 99.89% in equities, 0.49% in debt instruments. Managed by Amit Vora, it has delivered a return of 0.50% in the last year, a total return since inception of 15.28%.
Key Metrics of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular - Growth
-
Standard Deviation12.39%
-
Sharpe Ratio0.91%
-
Alpha-0.60%
-
Beta0.70%
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | -0.89% | -1.03% | 5.17% | 28.34% | 19.46% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | -0.96% | -1.26% | 4.29% | 27.26% | 18.41% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | -1.34% | -1.54% | 0.92% | 22.24% | 15.81% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | -1.44% | -1.85% | -0.36% | 20.63% | 14.17% |
More funds from Edelweiss Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct - Growth
|
₹166 | 0.71% | 4.37% | 7.40% | 7.36% | 19.05% |
|
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw
|
₹166 | 0.67% | 4.23% | 7.11% | 6.79% | 18.40% |
|
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct-idcw
|
₹166 | 0.71% | 4.37% | 7.40% | 7.36% | 19.05% |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | ₹40.09 | 27.26% | 18.41% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | ₹43.34 | 28.34% | 19.46% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | ₹33.96 | 22.24% | 15.81% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | ₹30.77 | 20.63% | 14.17% | - |
| ICICI Prudential Nifty Healthcare Etf - Growth |
₹146 | ₹150.90 | 22.45% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.13 | 22.62% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.50% | ₹20.19 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.45% | ₹18.96 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.16% | ₹18.74 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.16% | ₹18.74 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.89% | ₹17.72 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.89% | ₹17.72 Cr |
| Eli Lilly Forgn. Eq (lly) | Healthcare | 6.83% | ₹11.99 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.77% | ₹11.21 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.92% | ₹10.39 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.14% | ₹10.31 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.14% | ₹10.31 Cr |
| Cipla Ltd | Healthcare | 6.14% | ₹10.17 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.17% | ₹10.04 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.17% | ₹10.04 Cr |
| Cipla Ltd | Healthcare | 5.66% | ₹9.94 Cr |
| Cipla Ltd | Healthcare | 6.05% | ₹9.84 Cr |
| Cipla Ltd | Healthcare | 6.05% | ₹9.84 Cr |
| Cipla Ltd | Healthcare | 5.84% | ₹9.80 Cr |
| Cipla Ltd | Healthcare | 5.84% | ₹9.80 Cr |
| Eli Lilly Forgn. Eq (lly) | Healthcare | 5.75% | ₹9.65 Cr |
| Eli Lilly Forgn. Eq (lly) | Healthcare | 5.75% | ₹9.65 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.54% | ₹9.30 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.54% | ₹9.30 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.51% | ₹9.12 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.18% | ₹9.09 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.32% | ₹8.93 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.32% | ₹8.93 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.06% | ₹8.89 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.28% | ₹8.73 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.31% | ₹8.64 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.31% | ₹8.64 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 5.19% | ₹8.59 Cr |
| Eli Lilly Forgn. Eq (lly) | Healthcare | 5.25% | ₹8.54 Cr |
| Eli Lilly Forgn. Eq (lly) | Healthcare | 5.25% | ₹8.54 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 5.09% | ₹8.28 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 5.09% | ₹8.28 Cr |
| Eli Lilly Forgn. Eq (lly) | Healthcare | 4.98% | ₹8.24 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 4.81% | ₹8.08 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 4.81% | ₹8.08 Cr |
| Divi's Laboratories Ltd | Healthcare | 4.84% | ₹7.87 Cr |
| Divi's Laboratories Ltd | Healthcare | 4.84% | ₹7.87 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 4.47% | ₹7.84 Cr |
| Johnson & Johnson Ltd. Forgn. Eq (jnj) | Healthcare | 3.93% | ₹6.90 Cr |
| Johnson & Johnson Ltd. Forgn. Eq (jnj) | Healthcare | 3.75% | ₹6.30 Cr |
| Johnson & Johnson Ltd. Forgn. Eq (jnj) | Healthcare | 3.75% | ₹6.30 Cr |
| Johnson & Johnson Ltd. Forgn. Eq (jnj) | Healthcare | 3.80% | ₹6.19 Cr |
| Johnson & Johnson Ltd. Forgn. Eq (jnj) | Healthcare | 3.80% | ₹6.19 Cr |
| Lupin Ltd | Healthcare | 3.42% | ₹6.01 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.45% | ₹5.80 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.45% | ₹5.80 Cr |
| Abbvie Inc Forgn. Eq (abbv) | Healthcare | 3.49% | ₹5.68 Cr |
| Abbvie Inc Forgn. Eq (abbv) | Healthcare | 3.49% | ₹5.68 Cr |
| Abbvie Inc Forgn. Eq (abbv) | Healthcare | 3.17% | ₹5.57 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.39% | ₹5.51 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.39% | ₹5.51 Cr |
| Johnson & Johnson Ltd. Forgn. Eq (jnj) | Healthcare | 3.31% | ₹5.48 Cr |
| Abbvie Inc Forgn. Eq (abbv) | Healthcare | 3.18% | ₹5.34 Cr |
| Abbvie Inc Forgn. Eq (abbv) | Healthcare | 3.18% | ₹5.34 Cr |
| Fortis Healthcare Ltd | Healthcare | 2.95% | ₹5.18 Cr |
| Lupin Ltd | Healthcare | 3.08% | ₹5.18 Cr |
| Lupin Ltd | Healthcare | 3.08% | ₹5.18 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.10% | ₹5.13 Cr |
| Lupin Ltd | Healthcare | 3.08% | ₹5.10 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 2.88% | ₹5.06 Cr |
| Lupin Ltd | Healthcare | 3.11% | ₹5.05 Cr |
| Lupin Ltd | Healthcare | 3.11% | ₹5.05 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.04% | ₹4.94 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.04% | ₹4.94 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 2.90% | ₹4.87 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 2.90% | ₹4.87 Cr |
| Fortis Healthcare Ltd | Healthcare | 2.94% | ₹4.87 Cr |
| Abbvie Inc Forgn. Eq (abbv) | Healthcare | 2.79% | ₹4.62 Cr |
| Laurus Labs Ltd | Healthcare | 2.37% | ₹4.16 Cr |
| Laurus Labs Ltd | Healthcare | 2.30% | ₹3.86 Cr |
| Laurus Labs Ltd | Healthcare | 2.30% | ₹3.86 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.10% | ₹3.68 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.22% | ₹3.68 Cr |
| Merck & Co Inc (us) Forgn. Eq (mrk) | Healthcare | 2.07% | ₹3.63 Cr |
| Laurus Labs Ltd | Healthcare | 2.14% | ₹3.55 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.15% | ₹3.49 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.15% | ₹3.49 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.10% | ₹3.48 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.98% | ₹3.47 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.08% | ₹3.45 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.05% | ₹3.44 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.05% | ₹3.44 Cr |
| Novartis Ag Ads/adr (nvs) | Healthcare | 1.96% | ₹3.43 Cr |
| Laurus Labs Ltd | Healthcare | 2.10% | ₹3.42 Cr |
| Laurus Labs Ltd | Healthcare | 2.10% | ₹3.42 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.03% | ₹3.41 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.03% | ₹3.41 Cr |
| Novartis Ag Ads/adr (nvs) | Healthcare | 2.08% | ₹3.38 Cr |
| Novartis Ag Ads/adr (nvs) | Healthcare | 2.08% | ₹3.38 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.02% | ₹3.28 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.02% | ₹3.28 Cr |
| Novartis Ag Ads/adr (nvs) | Healthcare | 1.94% | ₹3.26 Cr |
| Novartis Ag Ads/adr (nvs) | Healthcare | 1.94% | ₹3.26 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.99% | ₹3.23 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.99% | ₹3.23 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.82% | ₹3.20 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.96% | ₹3.19 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.96% | ₹3.19 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.78% | ₹3.12 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.77% | ₹3.11 Cr |
| Thermo Fisher Scientific Inc Forgn. Eq (tmo) | Healthcare | 1.76% | ₹3.09 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.84% | ₹3.08 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.84% | ₹3.08 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.83% | ₹3.02 Cr |
| Merck & Co Inc (us) Forgn. Eq (mrk) | Healthcare | 1.78% | ₹2.99 Cr |
| Merck & Co Inc (us) Forgn. Eq (mrk) | Healthcare | 1.78% | ₹2.99 Cr |
| Novartis Ag Ads/adr (nvs) | Healthcare | 1.80% | ₹2.99 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.78% | ₹2.98 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.78% | ₹2.98 Cr |
| Thermo Fisher Scientific Inc Forgn. Eq (tmo) | Healthcare | 1.77% | ₹2.98 Cr |
| Thermo Fisher Scientific Inc Forgn. Eq (tmo) | Healthcare | 1.77% | ₹2.98 Cr |
| Merck & Co Inc (us) Forgn. Eq (mrk) | Healthcare | 1.80% | ₹2.92 Cr |
| Merck & Co Inc (us) Forgn. Eq (mrk) | Healthcare | 1.80% | ₹2.92 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.76% | ₹2.86 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.76% | ₹2.86 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 1.62% | ₹2.85 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.69% | ₹2.83 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.69% | ₹2.83 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.71% | ₹2.82 Cr |
| Merck & Co Inc (us) Forgn. Eq (mrk) | Healthcare | 1.64% | ₹2.71 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.59% | ₹2.66 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.59% | ₹2.66 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 1.58% | ₹2.66 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 1.58% | ₹2.66 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.62% | ₹2.63 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.62% | ₹2.63 Cr |
| Amgen Inc. (usa) Forgn. Eq (amgn) | Healthcare | 1.47% | ₹2.58 Cr |
| Thermo Fisher Scientific Inc Forgn. Eq (tmo) | Healthcare | 1.56% | ₹2.55 Cr |
| Thermo Fisher Scientific Inc Forgn. Eq (tmo) | Healthcare | 1.56% | ₹2.55 Cr |
| Novo Nordisk A/s Forgn. Eq (nvo) | Healthcare | 1.52% | ₹2.47 Cr |
| Novo Nordisk A/s Forgn. Eq (nvo) | Healthcare | 1.52% | ₹2.47 Cr |
| Biocon Ltd | Healthcare | 1.39% | ₹2.45 Cr |
| Alkem Laboratories Ltd | Healthcare | 1.47% | ₹2.44 Cr |
| Thermo Fisher Scientific Inc Forgn. Eq (tmo) | Healthcare | 1.47% | ₹2.44 Cr |
| Biocon Ltd | Healthcare | 1.46% | ₹2.42 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.44% | ₹2.38 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 1.44% | ₹2.38 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.33% | ₹2.33 Cr |
| Biocon Ltd | Healthcare | 1.37% | ₹2.30 Cr |
| Biocon Ltd | Healthcare | 1.37% | ₹2.30 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 1.37% | ₹2.23 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 1.37% | ₹2.23 Cr |
| Amgen Inc. (usa) Forgn. Eq (amgn) | Healthcare | 1.33% | ₹2.23 Cr |
| Amgen Inc. (usa) Forgn. Eq (amgn) | Healthcare | 1.33% | ₹2.23 Cr |
| Novo Nordisk A/s Forgn. Eq (nvo) | Healthcare | 1.25% | ₹2.20 Cr |
| Novo Nordisk A/s Forgn. Eq (nvo) | Healthcare | 1.31% | ₹2.20 Cr |
| Novo Nordisk A/s Forgn. Eq (nvo) | Healthcare | 1.31% | ₹2.20 Cr |
| Amgen Inc. (usa) Forgn. Eq (amgn) | Healthcare | 1.32% | ₹2.19 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.24% | ₹2.18 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.33% | ₹2.16 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.33% | ₹2.16 Cr |
| Gilead Sciences Inc. (usa) Forgn. Eq (gild) | Healthcare | 1.23% | ₹2.16 Cr |
| Biocon Ltd | Healthcare | 1.30% | ₹2.11 Cr |
| Biocon Ltd | Healthcare | 1.30% | ₹2.11 Cr |
| Amgen Inc. (usa) Forgn. Eq (amgn) | Healthcare | 1.29% | ₹2.11 Cr |
| Amgen Inc. (usa) Forgn. Eq (amgn) | Healthcare | 1.29% | ₹2.11 Cr |
| Gilead Sciences Inc. (usa) Forgn. Eq (gild) | Healthcare | 1.23% | ₹2.07 Cr |
| Gilead Sciences Inc. (usa) Forgn. Eq (gild) | Healthcare | 1.23% | ₹2.07 Cr |
| Novo Nordisk A/s Forgn. Eq (nvo) | Healthcare | 1.25% | ₹2.06 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.22% | ₹2.05 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.22% | ₹2.05 Cr |
| Danaher Corporation Forgn. Eq (dhr) | Healthcare | 1.15% | ₹2.02 Cr |
| Gilead Sciences Inc. (usa) Forgn. Eq (gild) | Healthcare | 1.17% | ₹1.93 Cr |
| Danaher Corporation Forgn. Eq (dhr) | Healthcare | 1.15% | ₹1.92 Cr |
| Danaher Corporation Forgn. Eq (dhr) | Healthcare | 1.15% | ₹1.92 Cr |
| Gilead Sciences Inc. (usa) Forgn. Eq (gild) | Healthcare | 1.18% | ₹1.92 Cr |
| Gilead Sciences Inc. (usa) Forgn. Eq (gild) | Healthcare | 1.18% | ₹1.92 Cr |
| Medtronic Forgn. Eq (mdt) | Healthcare | 1.07% | ₹1.87 Cr |
| Stryker Corp Forgn. Eq (syk) | Healthcare | 1.12% | ₹1.86 Cr |
| Danaher Corporation Forgn. Eq (dhr) | Healthcare | 1.09% | ₹1.77 Cr |
| Danaher Corporation Forgn. Eq (dhr) | Healthcare | 1.09% | ₹1.77 Cr |
| Gland Pharma Ltd | Healthcare | 1.07% | ₹1.77 Cr |
| Stryker Corp Forgn. Eq (syk) | Healthcare | 1.01% | ₹1.77 Cr |
| Stryker Corp Forgn. Eq (syk) | Healthcare | 1.09% | ₹1.77 Cr |
| Stryker Corp Forgn. Eq (syk) | Healthcare | 1.09% | ₹1.77 Cr |
| Danaher Corporation Forgn. Eq (dhr) | Healthcare | 1.06% | ₹1.76 Cr |
| Gland Pharma Ltd | Healthcare | 1.05% | ₹1.71 Cr |
| Gland Pharma Ltd | Healthcare | 1.05% | ₹1.71 Cr |
| Stryker Corp Forgn. Eq (syk) | Healthcare | 1.01% | ₹1.70 Cr |
| Stryker Corp Forgn. Eq (syk) | Healthcare | 1.01% | ₹1.70 Cr |
| Medtronic Forgn. Eq (mdt) | Healthcare | 1.04% | ₹1.69 Cr |
| Medtronic Forgn. Eq (mdt) | Healthcare | 1.04% | ₹1.69 Cr |
| Gland Pharma Ltd | Healthcare | 0.98% | ₹1.65 Cr |
| Gland Pharma Ltd | Healthcare | 0.98% | ₹1.65 Cr |
| Vertex Pharmaceuticals Inc. (usa) Forgn. Eq (vrtx) | Healthcare | 0.98% | ₹1.62 Cr |
| Medtronic Forgn. Eq (mdt) | Healthcare | 0.96% | ₹1.61 Cr |
| Medtronic Forgn. Eq (mdt) | Healthcare | 0.96% | ₹1.61 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 0.91% | ₹1.60 Cr |
| Medtronic Forgn. Eq (mdt) | Healthcare | 0.97% | ₹1.60 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 0.96% | ₹1.59 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.94% | ₹1.55 Cr |
| Vertex Pharmaceuticals Inc. (usa) Forgn. Eq (vrtx) | Healthcare | 0.88% | ₹1.54 Cr |
| Vertex Pharmaceuticals Inc. (usa) Forgn. Eq (vrtx) | Healthcare | 0.90% | ₹1.52 Cr |
| Vertex Pharmaceuticals Inc. (usa) Forgn. Eq (vrtx) | Healthcare | 0.90% | ₹1.52 Cr |
| Gland Pharma Ltd | Healthcare | 0.85% | ₹1.50 Cr |
| Syngene International Ltd | Healthcare | 0.90% | ₹1.50 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 0.86% | ₹1.45 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 0.86% | ₹1.45 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 0.88% | ₹1.44 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 0.88% | ₹1.44 Cr |
| Vertex Pharmaceuticals Inc. (usa) Forgn. Eq (vrtx) | Healthcare | 0.86% | ₹1.40 Cr |
| Vertex Pharmaceuticals Inc. (usa) Forgn. Eq (vrtx) | Healthcare | 0.86% | ₹1.40 Cr |
| Ajanta Pharma Ltd | Healthcare | 0.84% | ₹1.39 Cr |
| Piramal Pharma Ltd | Healthcare | 0.82% | ₹1.38 Cr |
| Piramal Pharma Ltd | Healthcare | 0.82% | ₹1.38 Cr |
| Syngene International Ltd | Healthcare | 0.81% | ₹1.36 Cr |
| Syngene International Ltd | Healthcare | 0.81% | ₹1.36 Cr |
| Piramal Pharma Ltd | Healthcare | 0.82% | ₹1.36 Cr |
| Syngene International Ltd | Healthcare | 0.77% | ₹1.35 Cr |
| Piramal Pharma Ltd | Healthcare | 0.81% | ₹1.32 Cr |
| Piramal Pharma Ltd | Healthcare | 0.81% | ₹1.32 Cr |
| Syngene International Ltd | Healthcare | 0.80% | ₹1.31 Cr |
| Syngene International Ltd | Healthcare | 0.80% | ₹1.31 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.80% | ₹1.30 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.80% | ₹1.30 Cr |
| Piramal Pharma Ltd | Healthcare | 0.73% | ₹1.29 Cr |
| Ajanta Pharma Ltd | Healthcare | 0.73% | ₹1.29 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.76% | ₹1.28 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.76% | ₹1.28 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.71% | ₹1.25 Cr |
| Ajanta Pharma Ltd | Healthcare | 0.74% | ₹1.24 Cr |
| Ajanta Pharma Ltd | Healthcare | 0.74% | ₹1.24 Cr |
| Global Health Ltd | Healthcare | 0.75% | ₹1.23 Cr |
| Global Health Ltd | Healthcare | 0.75% | ₹1.23 Cr |
| Global Health Ltd | Healthcare | 0.74% | ₹1.22 Cr |
| Global Health Ltd | Healthcare | 0.73% | ₹1.22 Cr |
| Global Health Ltd | Healthcare | 0.73% | ₹1.22 Cr |
| Ajanta Pharma Ltd | Healthcare | 0.75% | ₹1.22 Cr |
| Ajanta Pharma Ltd | Healthcare | 0.75% | ₹1.22 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.71% | ₹1.18 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.72% | ₹1.17 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.72% | ₹1.17 Cr |
| Global Health Ltd | Healthcare | 0.66% | ₹1.15 Cr |
| Regeneron Pharmaceuticals Inc Forgn. Eq (regn) | Healthcare | 0.64% | ₹1.13 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.59% | ₹1.00 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.59% | ₹1.00 Cr |
| Regeneron Pharmaceuticals Inc Forgn. Eq (regn) | Healthcare | 0.58% | ₹0.97 Cr |
| Regeneron Pharmaceuticals Inc Forgn. Eq (regn) | Healthcare | 0.58% | ₹0.97 Cr |
| Others Cblo | Unspecified | 0.49% | ₹0.86 Cr |
| Regeneron Pharmaceuticals Inc Forgn. Eq (regn) | Healthcare | 0.51% | ₹0.83 Cr |
| Regeneron Pharmaceuticals Inc Forgn. Eq (regn) | Healthcare | 0.51% | ₹0.83 Cr |
| Regeneron Pharmaceuticals Inc Forgn. Eq (regn) | Healthcare | 0.48% | ₹0.80 Cr |
| Becton Dickinson And Co Forgn. Eq (bdx) | Healthcare | 0.44% | ₹0.77 Cr |
| Becton Dickinson And Co Forgn. Eq (bdx) | Healthcare | 0.46% | ₹0.74 Cr |
| Becton Dickinson And Co Forgn. Eq (bdx) | Healthcare | 0.46% | ₹0.74 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.42% | ₹0.74 Cr |
| Becton Dickinson And Co Forgn. Eq (bdx) | Healthcare | 0.42% | ₹0.71 Cr |
| Becton Dickinson And Co Forgn. Eq (bdx) | Healthcare | 0.42% | ₹0.71 Cr |
| Becton Dickinson And Co Forgn. Eq (bdx) | Healthcare | 0.42% | ₹0.70 Cr |
| Agilent Technologies Inc Forgn. Eq (a) | Healthcare | 0.34% | ₹0.60 Cr |
| Agilent Technologies Inc Forgn. Eq (a) | Healthcare | 0.34% | ₹0.58 Cr |
| Agilent Technologies Inc Forgn. Eq (a) | Healthcare | 0.34% | ₹0.58 Cr |
| Iqvia Holdings Forgn. Eq (iqv) | Healthcare | 0.31% | ₹0.54 Cr |
| Iqvia Holdings Forgn. Eq (iqv) | Healthcare | 0.31% | ₹0.52 Cr |
| Iqvia Holdings Forgn. Eq (iqv) | Healthcare | 0.31% | ₹0.52 Cr |
| Agilent Technologies Inc Forgn. Eq (a) | Healthcare | 0.31% | ₹0.51 Cr |
| Agilent Technologies Inc Forgn. Eq (a) | Healthcare | 0.31% | ₹0.51 Cr |
| Iqvia Holdings Forgn. Eq (iqv) | Healthcare | 0.28% | ₹0.46 Cr |
| Iqvia Holdings Forgn. Eq (iqv) | Healthcare | 0.28% | ₹0.46 Cr |
| Iqvia Holdings Forgn. Eq (iqv) | Healthcare | 0.27% | ₹0.45 Cr |
| Agilent Technologies Inc Forgn. Eq (a) | Healthcare | 0.27% | ₹0.45 Cr |
| Others Cblo | Unspecified | 0.25% | ₹0.42 Cr |
| Illumina Inc. (usa) Forgn. Eq (ilmn) | Healthcare | 0.16% | ₹0.28 Cr |
| Illumina Inc. (usa) Forgn. Eq (ilmn) | Healthcare | 0.16% | ₹0.27 Cr |
| Illumina Inc. (usa) Forgn. Eq (ilmn) | Healthcare | 0.16% | ₹0.27 Cr |
| Others Cblo | Unspecified | 0.15% | ₹0.26 Cr |
| Others Cblo | Unspecified | 0.15% | ₹0.26 Cr |
| Net Receivables | Unspecified | 0.10% | ₹0.23 Cr |
| Net Receivables | Unspecified | 0.10% | ₹0.23 Cr |
| Illumina Inc. (usa) Forgn. Eq (ilmn) | Healthcare | 0.13% | ₹0.22 Cr |
| Illumina Inc. (usa) Forgn. Eq (ilmn) | Healthcare | 0.13% | ₹0.21 Cr |
| Illumina Inc. (usa) Forgn. Eq (ilmn) | Healthcare | 0.13% | ₹0.21 Cr |
| Others Cblo | Unspecified | 0.11% | ₹0.18 Cr |
| Others Cblo | Unspecified | 0.11% | ₹0.18 Cr |
| Cash | Unspecified | 0.00% | ₹0.00 Cr |
| Cash | Unspecified | 0.00% | ₹0.00 Cr |
| Cash | Unspecified | 0.00% | ₹0.00 Cr |
| Cash | Unspecified | 0.00% | ₹0.00 Cr |
| Cash | Unspecified | 0.00% | ₹0.00 Cr |
| Cash | Unspecified | 0.00% | ₹0.00 Cr |
| Net Payables | Unspecified | -0.01% | ₹-0.03 Cr |
| Net Payables | Unspecified | -0.05% | ₹-0.08 Cr |
| Net Payables | Unspecified | -0.05% | ₹-0.08 Cr |
| Net Payables | Unspecified | -0.38% | ₹-0.69 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹43.34 | 28.34% | 19.46% | 44.69 |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹40.09 | 27.26% | 18.41% | 41.47 |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹33.96 | 22.24% | 15.81% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹30.77 | 20.63% | 14.17% | - |
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular - Growth
What is the current AUM of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular - Growth?
As of Thu Jul 31, 2025, Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular - Growth manages assets worth ₹165.5 crore
How has Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular - Growth performed recently?
- 3 Months: 3.19%
- 6 Months: 11.68%
What is the long-term performance of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular - Growth?
- 3 Years CAGR: 19.13%
- Since Inception: 15.28%
What is the portfolio composition of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular - Growth?
Equity: 99.89%, Debt: 0.49%, Others: -0.38%.
Who manages Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular - Growth?
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular - Growth is managed by Amit Vora from Edelweiss Mutual Fund.
What is the market-cap allocation of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular - Growth?
Large Cap: 80.30%, Mid Cap: 16.93%, Small Cap: 2.77%.
Which are the top companies Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular - Growth has invested in?
- Sun Pharmaceutical Industries Ltd – 11.50% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 11.45% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 11.16% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 11.16% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.89% of the fund's portfolio
Which are the major sectors Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular - Growth focuses on?
- Healthcare – 598.93% of the fund's portfolio
- Unspecified – 0.97% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.


